March 31, 2020
Read the full article: Les Echos
Due to Health emergency, the biotechnology company is launching this Tuesday its rapid diagnostic test for Covid-19 and plans to market 70,000 as of April, then to increase to 2 million per month. This capillary test obtained the CE mark after being validated following a campaign of clinical evaluations, in particular at the Lariboisière hospital and the AP-HP Université Paris Saclay.
